Heterocyclic autotaxin inhibitors and uses thereof
WO2012138797A1
3- or 5 - bi phenyl - 4 - ylisoxazole - based compounds useful for the treatment of fibrosis, pain, cancer and respiratory, allergic, nervous system or cardiovascular disorders
SG191041A1
Polycyclic lpa1 antagonist and uses thereof
MX2013006040A
Lysophosphatidic acid receptor antagonists and their use in the treatment fibrosis.
CN103201262A
Autotaxin inhibitors and uses thereof
WO2011159633A1
Inhalable formulations of lysophosphatdic acid receptor antagonists
WO2011159635A1
Lysophosphatidic acid receptor antagonist for the treatment of dermal conditions
WO2011159550A2
Lysophosphatidic acid receptor antagonist and uses thereof
CN102812000A
Dp2 Antagonist And Uses Thereof
WO2011049979A2
Injectable formulations for intra- articular or peri-articular administration
GB201016314D0
Compounds as Lysophosphatidic acid receptor antagonists
GB201016312D0
Polycyclic compounds as lysophosphatidic acid receptor antagonists
WO2011038086A2
Indolizine inhibitors of 5-lipoxygenase
WO2011038097A2
Indolizine inhibitors of 5-lipoxygenase
WO2011017201A2
Dp2 antagonist and uses thereof
WO2011014587A2
Ophthalmic pharmaceutical compositions of dp2 receptor antagonists
GB201009231D0
Polycyclic antagonists of lysophosphatidic acid receptors
WO2010085820A2
Tricyclic compounds as antagonists of prostaglandin d2 receptors
